ViciniVax B.V   Report issue

For profit Phase 1
Founded: Groningen Netherlands (2011)
Status: Left NME R&D (2022)

Organization Overview

First Clinical Trial
2017
NCT03141463
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now